Real-life Data on the Safety and Tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) Patients: A Single-Centre Study

被引：0
|
作者：
Thong, L. [1 ]
Bowen, B. [1 ]
Henry, M. T. [1 ]
机构：
[1] Cork Univ Hosp, Dept Resp Med, Cork, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2021年 / 190卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2.1.3
引用
收藏
页码：S28 / S29
页数：2
相关论文
共 50 条
  • [1] Real-life data on the safety and tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) patients: A single-centre retrospective study
    Yin, Lorraine Thong Wan
    Bowen, Bernadette
    Henry, Micahel
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience
    Pianigiani, Lucrezia
    Fui, Annalisa
    Cameli, Paolo
    Carobene, Loredana
    Refini, Rosa Metella
    Pieroni, Maria
    Fossi, Antonella
    Bennett, David
    Rottoli, Paola
    Valentini, Maria Lucia
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [3] Real-life experience with pirfenidone in idiopathic pulmonary fibrosis (IPF) in a single centre in Italy. A retrospective study
    Tavanti, Laura
    De Magistris, Sara
    Romei, Chiara
    Perrone, Elisabetta
    Falaschi, Fabio
    Nieri, Dario
    Serradori, Massimiliano
    Celi, Alessandro
    Palla, Antonio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [4] Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre
    Bargagli, E.
    Piccioli, C.
    Rosi, E.
    Torricelli, E.
    Turi, L.
    Piccioli, E.
    Pistolesi, M.
    Ferrari, K.
    Voltolini, L.
    [J]. PULMONOLOGY, 2019, 25 (03): : 149 - 153
  • [5] Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
    Cameli, Paolo
    Bergantini, Laura
    D'Alessandro, Miriana
    Refini, Rosa Metella
    Pieroni, Maria
    Alonzi, Valerio
    Sestini, Piersante
    Bargagli, Elena
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [6] Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Flaherty, K.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison
    Mazzoleni, Ludovica
    Borsino, Cecilia
    Zovi, Andrea
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (02) : E11 - E11
  • [8] SINGLE CENTRE EXPERIENCE OF THE REAL-LIFE IMPACT OF PIRFENIDONE ON LUNG FUNCTION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Rathnapala, A.
    Fries, A.
    West, Y.
    Ho, L. P.
    Hoyles, R. K.
    [J]. THORAX, 2016, 71 : A179 - A179
  • [9] SAFETY OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS: A REAL-LIFE STUDY AT OUR HOSPITAL
    Okamoto, Mariko
    Saji, Junko
    Kanno, Yuki
    Tsunoda, Akihito
    Komatsubara, Yuka
    Onoe, Rintaro
    Furuya, Naoki
    Inoue, Takeo
    Miyazawa, Teruomi
    Mineshita, Masamichi
    [J]. RESPIROLOGY, 2018, 23 : 160 - 161
  • [10] Safety, Tolerability and Efficacy of Nintedanib Switched from Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Ikeda, S.
    Sekine, A.
    Baba, T.
    Katano, T.
    Matama, G.
    Aiko, N.
    Isomoto, K.
    Otoshi, R.
    Tabata, E.
    Shintani, R.
    Sadoyama, S.
    Yamakawa, H.
    Niwa, T.
    Nakagawa, H.
    Oda, T.
    Okuda, R.
    Kitamura, H.
    Komatsu, S.
    Hagiwara, E.
    Ogura, T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345